FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076158450> ?p ?o ?g. }

• W2076158450 endingPage "1307" @default.
• W2076158450 startingPage "1296" @default.
• W2076158450 abstract "Sarcoidosis is characterised by non-caseating granulomas that secrete pro-inflammatory cytokines, including interleukin (IL)-12, IL-23, and tumour necrosis factor (TNF)-α. Ustekinumab and golimumab are monoclonal antibodies that specifically inhibit IL-12/IL-23 and TNF-α, respectively. Patients with chronic pulmonary sarcoidosis (lung group) and/or skin sarcoidosis (skin group) received either 180 mg ustekinumab at week 0 followed by 90 mg every 8 weeks, 200 mg golimumab at week 0 followed by 100 mg every 4 weeks, or placebo. Patients underwent corticosteroid tapering between weeks 16 and 28. The primary end-point was week 16 change in percentage predicted forced vital capacity (ΔFVC % pred) in the lung group. Major secondary end-points were: week 28 for ΔFVC % pred, 6-min walking distance, St George's Respiratory Questionnaire (lung group), and Skin Physician Global Assessment response (skin group). At week 16, no significant differences were observed in ΔFVC % pred with ustekinumab (-0.15, p = 0.13) or golimumab (1.15, p = 0.54) compared with placebo (2.02). At week 28, there were no significant improvements in the major secondary end-points, although a nonsignificant numerically greater Skin Physician Global Assessment response was observed following golimumab treatment (53%) when compared with the placebo (30%). Serious adverse events were similar in all treatment groups. Although treatment was well tolerated, neither ustekinumab nor golimumab demonstrated efficacy in pulmonary sarcoidosis. However, trends towards improvement were observed with golimumab in some dermatological end-points." @default.
• W2076158450 created "2016-06-24" @default.
• W2076158450 creator A5000132079 @default.
• W2076158450 creator A5003992000 @default.
• W2076158450 creator A5021656163 @default.
• W2076158450 creator A5022605552 @default.
• W2076158450 creator A5031289561 @default.
• W2076158450 creator A5037076836 @default.
• W2076158450 creator A5038846995 @default.
• W2076158450 creator A5041237897 @default.
• W2076158450 creator A5044008235 @default.
• W2076158450 creator A5044597853 @default.
• W2076158450 creator A5050795000 @default.
• W2076158450 creator A5056074524 @default.
• W2076158450 creator A5057919376 @default.
• W2076158450 creator A5058402241 @default.
• W2076158450 creator A5075176692 @default.
• W2076158450 creator A5076833457 @default.
• W2076158450 creator A5090203143 @default.
• W2076158450 date "2014-07-17" @default.
• W2076158450 modified "2023-10-14" @default.
• W2076158450 title "Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis" @default.
• W2076158450 cites W114071489 @default.
• W2076158450 cites W1691776691 @default.
• W2076158450 cites W1967956104 @default.
• W2076158450 cites W1984284310 @default.
• W2076158450 cites W1987208829 @default.
• W2076158450 cites W1999376185 @default.
• W2076158450 cites W2008294070 @default.
• W2076158450 cites W2022849814 @default.
• W2076158450 cites W2039158723 @default.
• W2076158450 cites W2040958678 @default.
• W2076158450 cites W2046362689 @default.
• W2076158450 cites W2046898725 @default.
• W2076158450 cites W2067935369 @default.
• W2076158450 cites W2077078102 @default.
• W2076158450 cites W2080074829 @default.
• W2076158450 cites W2088228080 @default.
• W2076158450 cites W2100052996 @default.
• W2076158450 cites W2106341068 @default.
• W2076158450 cites W2110255826 @default.
• W2076158450 cites W2110749959 @default.
• W2076158450 cites W2111252491 @default.
• W2076158450 cites W2114911311 @default.
• W2076158450 cites W2117206496 @default.
• W2076158450 cites W2117964443 @default.
• W2076158450 cites W2122408285 @default.
• W2076158450 cites W2130860647 @default.
• W2076158450 cites W2131718547 @default.
• W2076158450 cites W2138783361 @default.
• W2076158450 cites W2142665211 @default.
• W2076158450 cites W2154921150 @default.
• W2076158450 cites W2168330263 @default.
• W2076158450 cites W2292179202 @default.
• W2076158450 cites W3023241955 @default.
• W2076158450 cites W3044135283 @default.
• W2076158450 cites W4210995779 @default.
• W2076158450 cites W4211032738 @default.
• W2076158450 cites W4231712470 @default.
• W2076158450 cites W4292806894 @default.
• W2076158450 doi "https://doi.org/10.1183/09031936.00000914" @default.
• W2076158450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25034562" @default.
• W2076158450 hasPublicationYear "2014" @default.
• W2076158450 type Work @default.
• W2076158450 sameAs 2076158450 @default.
• W2076158450 citedByCount "165" @default.
• W2076158450 countsByYear W20761584502014 @default.
• W2076158450 countsByYear W20761584502015 @default.
• W2076158450 countsByYear W20761584502016 @default.
• W2076158450 countsByYear W20761584502017 @default.
• W2076158450 countsByYear W20761584502018 @default.
• W2076158450 countsByYear W20761584502019 @default.
• W2076158450 countsByYear W20761584502020 @default.
• W2076158450 countsByYear W20761584502021 @default.
• W2076158450 countsByYear W20761584502022 @default.
• W2076158450 countsByYear W20761584502023 @default.
• W2076158450 crossrefType "journal-article" @default.
• W2076158450 hasAuthorship W2076158450A5000132079 @default.
• W2076158450 hasAuthorship W2076158450A5003992000 @default.
• W2076158450 hasAuthorship W2076158450A5021656163 @default.
• W2076158450 hasAuthorship W2076158450A5022605552 @default.
• W2076158450 hasAuthorship W2076158450A5031289561 @default.
• W2076158450 hasAuthorship W2076158450A5037076836 @default.
• W2076158450 hasAuthorship W2076158450A5038846995 @default.
• W2076158450 hasAuthorship W2076158450A5041237897 @default.
• W2076158450 hasAuthorship W2076158450A5044008235 @default.
• W2076158450 hasAuthorship W2076158450A5044597853 @default.
• W2076158450 hasAuthorship W2076158450A5050795000 @default.
• W2076158450 hasAuthorship W2076158450A5056074524 @default.
• W2076158450 hasAuthorship W2076158450A5057919376 @default.
• W2076158450 hasAuthorship W2076158450A5058402241 @default.
• W2076158450 hasAuthorship W2076158450A5075176692 @default.
• W2076158450 hasAuthorship W2076158450A5076833457 @default.
• W2076158450 hasAuthorship W2076158450A5090203143 @default.
• W2076158450 hasBestOaLocation W20761584501 @default.
• W2076158450 hasConcept C126322002 @default.
• W2076158450 hasConcept C142724271 @default.
• W2076158450 hasConcept C165637977 @default.

• next